PDCD1 and neoplasm: On the other hand, a synergistic antitumor effect has been demonstrated on combined blockade of both IL-6 signaling and PD-1/PD-L1 pathways in tumor-bearing mice43, suggesting the efficacy of the dual signal blockade in terms of resolving the symptoms of irAEs without interfering antitumor effects.